Research Articles | Page 27 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

  1. Home
  2. Research

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
To Target the Untargetable: Elucidation of Synergy of APR-246 and Azacitidine in TP53 Mutant Myelodysplastic Syndromes and Acute Myeloid Leukemia Jun 2020 Haematologica Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Significant hemolysis is not required for thrombosis in paroxysmal nocturnal hemoglobinuria. Mar 2019 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes Apr 2023 Haematologica Myelodysplastic Syndromes (MDS)
Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation Mar 2024 Haematologica Aplastic Anemia
Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society of Blood and Marrow Transplantation May 2023 Haematologica Aplastic Anemia
Diagnosis of myelodysplastic syndromes: the classic and the novel Oct 2024 Haematologica Myelodysplastic Syndromes (MDS)
Use of Immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis Apr 2019 Haemotologica Myelodysplastic Syndromes (MDS)
Thrombosis at Unusual Sites: Focus on Myeloproliferative Neoplasms and Paroxysmal Nocturnal Hemoglobinuria Feb 2025 Hamostaseologie Myeloproliferative Neoplasms (MPN), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation? Jul 2024 HemaSphere Myelodysplastic Syndromes (MDS)
Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS) May 2024 HemaSphere Myelodysplastic Syndromes (MDS)